TRILLIUM THERAPEUTICS
Trillium Therapeutics Inc. operates as a biopharmaceutical research and development company. It focuses on the immune system and its regulation. The company specializes in the discovery and development of protein therapeutics, such as monoclonal antibodies, secreted proteins, and peptides. It involves in therapeutic areas, including autoimmune disease, cancer, necrotizing enterocolitis, and transplantation. Trillium Therapeutics Inc. was formerly known as Transplantation Technologies Inc. and changed its name in May 2003. The company was founded in 1996 and is based in Toronto, Canada.
TRILLIUM THERAPEUTICS
Industry:
Biopharma Biotechnology Clinical Trials Health Care Therapeutics
Founded:
2004-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.trilliumtherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
416-595-0627
Email Addresses:
[email protected]
Total Funding:
45.98 M USD
Technology used in webpage:
SPF Euro Google Maps Cloudflare Google Maps API Cloudflare SSL Cloudflare Bot Manager Proofpoint DocuSign Intermedia
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Epizyme
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.
ES Cell International
ESI BIO’s mission is to be our customer’s trusted partner in translating scientific discoveries to the clinic.
GlycoMimetics
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
Krystal Biotech
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-01-28 | Fluorinov Pharma | Fluorinov Pharma acquired by Trillium Therapeutics | 32 M USD |
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Trillium Therapeutics
Pfizer Breakthrough Growth Initiative
Pfizer Breakthrough Growth Initiative investment in Post-IPO Equity - Trillium Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Trillium Therapeutics
BDC Venture Capital
BDC Venture Capital investment in Seed Round - Trillium Therapeutics
Official Site Inspections
http://www.trilliumtherapeutics.com
- Host name: 192.29.61.237
- IP address: 192.29.61.237
- Location: Zurich Switzerland
- Latitude: 47.4049
- Longitude: 8.4631
- Timezone: Europe/Zurich
- Postal: 8102
